1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow GS 101: new trials by email Literature Review of GS 101 trials Research Report on GS 101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection GS101 injection, U.S. commercial Dupixent®, CN commercial Dupixent® - Atopic Dermatitis (AD) | Phase 1 | Completed | Jiangsu Genscend Biopharmaceutical Co., Ltd | 294 | 2026-03-05 | 2026-10-15 |
Jiangsu Genscend Biopharmaceutical Co., Ltd (1)
China (1)